---
title: "Furja's partial shareholders completed the reduction of 449,000 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232374919.md"
description: "According to the Zhitong Finance APP, Furja announced that as of March 19, 2025, the company's shareholders Shen Ying and Liao Wankui have decided to terminate this reduction plan early, and the shares not reduced will not be reduced again during the original reduction plan period. The above shareholders have reduced a total of 449,000 shares of the company through centralized bidding trading, accounting for 0.0800% of the company's total share capital"
datetime: "2025-03-19T08:28:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232374919.md)
  - [en](https://longbridge.com/en/news/232374919.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232374919.md)
generator: "portal-rs"
---

# Furja's partial shareholders completed the reduction of 449,000 shares

According to the Zhitong Finance APP, Furja (603219.SH) announced that as of March 19, 2025, the company's shareholders Shen Ying and Liao Wankui have decided to terminate this reduction plan early, and the shares not reduced will not be reduced again during the original reduction plan period. The aforementioned shareholders have reduced a total of 449,000 shares of the company through centralized bidding trading, accounting for 0.0800% of the company's total share capital

### Related Stocks

- [603219.CN](https://longbridge.com/en/quote/603219.CN.md)

## Related News & Research

- [REG - Mercantile Inv Tst - Holding(s) in Company](https://longbridge.com/en/news/296774796.md)
- [EDM Announces Results of the Annual General Meeting | EDMFF Stock News](https://longbridge.com/en/news/296781083.md)
- [Tesi sees Finnish defence, dual-use startups’ net sales topping EUR 600 million in 2025](https://longbridge.com/en/news/296829028.md)
- [Chicago Atlantic BDC Co-CIO Scott Gordon acquires $89,313 of common shares](https://longbridge.com/en/news/296828416.md)
- [America Great Health reports interim data from ion-modified peptide adjunctive therapy observational study in solid tumors](https://longbridge.com/en/news/296824338.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**